Tumor immune archetypes at single cell resolution

How would you propose to identify immune archetypes in the tumor microenvironment using single cell and spatial omics data, leveraging advances in data science and AI?

Youli Xia
Bino John
Abhi Kashyap

Youli Xia, Bino John, and Abhishek Kashyap
Global Computational Biology and Data Science, Oncology Research

No solution found

Novel strategies to selectively target adipose tissue

How would you propose to identify and verify novel approaches to specifically target adipose tissue for delivery of anti-obesity therapeutics?

Daniel Markgraf

Daniel Markgraf 
Principal Scientist 
Boehringer Ingelheim

Solved

Eco-friendly TFA-free solid-phase peptide synthesis

How would you propose to avoid the use of trifluoroacetic acid (TFA) for resin cleavage and deprotection of synthetic peptides using an alternative reagent cocktail, to advance more sustainable peptide synthesis?

Albert Brennauer

Albert Brennauer  
Development NCE 
Boehringer Ingelheim

Solved

Spatial multi-omics profiling of fibrotic diseases

How would you propose to leverage novel spatial multi-omics to investigate molecular and cellular mechanisms driving human fibrotic disease suitable for computational analyses?

Aleksandra Ivovic
Frank Li

Aleksandra Ivovic, Frank Li  
Global Computational Biology & Data Science  
Boehringer Ingelheim

No solution found

Unravel the role of AGR2 in lung fibrosis

How would you propose to investigate and confirm the mechanistic roles of intracellular versus secreted anterior gradient 2 (AGR2) in the progression of lung fibrosis using disease relevant cellular models?

Heiko Stahl
Wolfgang Reindl

Heiko Stahl, Wolfgang Reindl   
Immunology & Respiratory Research / Biotherapeutics Discovery   
Boehringer Ingelheim

Latest active call

double helix
67

Tumor immune archetypes at single cell resolution

Collaborate with us

Hear from our collaborators

opnMe facilitated an efficient research partnership with Boehringer Ingelheim, accelerating the discovery of bioactive peptides. opnMe enabled us to combine expertise and resources, therefore leveraging the strengths of both organizations to achieve innovative outcomes.

CMO, PXBioVisioN GmbH, Hannover

I found the opnMe portal very easy to navigate and use. The application process is straightforward; this can be achieved in one afternoon. The time from submission to decision is one of the fastest turnarounds I have had, and this aspect makes a real difference in the momentum of pursuing a scientific idea.

Associate Professor, University College London

With the help of opnMe, we teamed up with Boehringer Ingelheim to develop a human-in-the-loop AI solution for pre-clinical research. We’re excited to see the tool in active use, having a measurable positive impact on the daily work of the scientists and increasing the safety of drug discovery.

CTO, Merantix Momentum GmbH, Berlin

As an academic postdoc, opnMe provided me with the opportunity to apply my skills in a "semi-industry" setting. Collaborating with Boehringer Ingelheim’s experts on pharmacologically relevant questions in neuroscience was particularly exciting, as it aligns with my deep passion for the field.

Senior Research Fellow, Temasek Life Sciences Laboratory, Singapore

opnMe represents a great concept of open science in two ways: It allows Boehringer to stimulate research at the forefront of scientific discovery within a well-defined disease area and it allows academics to excel by approaching Boehringer Ingelheim with proactive, innovative ideas.

Vice President Research, ETH Zurich

opnMe's expert guidance was pivotal in forging our research collaboration with Boehringer Ingelheim. Their initiative seamlessly bridged the gap between academic and industry research, uniting foundational biomedical science with application-oriented translational animal health research.

Associate Professor, City University of Hong Kong

It has been a pleasure for me to participate in opnMe. In addition to providing funding for our research project, it has given my lab an opportunity to collaborate with excellent people at Boehringer Ingelheim, generated some exciting results, and taught us new things about brain circuitry.

Senior Investigator, Temasek Life Sciences Laboratory, Singapore

FAQs

opn2EXPERTS

How can I upload a modified version of my proposal after submission?

opn2EXPERTS

Who owns any potential IP arising from novel experimental observations?

opn2EXPERTS

Will other applicants be able to see my collaboration proposal?

opn2EXPERTS

How long does the proposal review take after my submission?

opn2EXPERTS

Is funding available to support the experimental plan outlined in the proposed answer?

opn2EXPERTS

What if I have additional confidential information?

opn2EXPERTS

What are the key success criteria on which we base our selection for the best answer?

opn2EXPERTS

What should be key elements of a “good” proposal?

opn2EXPERTS

How do I submit and what are the requirements?

opn2EXPERTS

What are the benefits of submitting an answer for this opn2EXPERTS question for me?

opn2EXPERTS

What questions do we ask as part of the opn2EXPERTS program on opnMe?

Collaborate with us

Explore other
collaboration opportunities

Collaborate with us vial icon

Collaborate with us on molecules.

Rocket

Partner with us on technology with techMATCH.